TOB1 and myeloid sarcoma: Similarly, miR-590 is upregulated in relapse-MS patients to promote the differentiation of Th17 cells by targeting Tob1 (Transducer of Erb-2), a member of the Tob/BTG anti-proliferative family of proteins (Liu Q. et al., 2017).